<

HBM HEALTHCARE INVESTMENTS AG (FRA:CH001262) EQS-Adhoc: Changes to the Board of Directors of HBM Healthcare Investments Ltd

Transparency directive : regulatory news

07/05/2021 07:18

EQS Group-Ad-hoc: HBM Healthcare Investments AG / Key word(s): Annual Results
Changes to the Board of Directors of HBM Healthcare Investments Ltd

07-May-2021 / 07:18 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 KR
The issuer is solely responsible for the content of this announcement.


Media Release

Follow us on  img@HbmHealthcare

Zug, 7 May 2021

Board of Directors of HBM Healthcare Investments Ltd proposes Dr Elaine V. Jones, an experienced and well connected executive, to be elected to the Board of Directors at the Shareholders' Meeting on 18 June 2021. In this regard, the Company refers to its announcement of 2 November 2020. 

Dr Jones has more than 20 years of investment experience in venture capital financing, focusing on biosciences. For more than ten years, she was vice-president at Pfizer Ventures with responsibility for managing investments in biotechnology and healthcare companies. Prior to that, Dr Jones worked at EuclidSR Partners and at SR One, the former venture capital fund of GlaxoSmithKline.

The three long-standing members of the Board of Directors, Prof. Dr Heinz Riesenhuber (Vice Chairman), Dr Eduard E. Holdener and Robert A. Ingram, are retiring and therefore not standing for re-election at the forthcoming Shareholders' Meeting . 

'Over the last two decades, Heinz, Ed and Bob have been instrumental in establishing and building up our company. On behalf of the Board of Directors and the Mangement I thank them for their valuable services and enormous commitment  over the years and wish them all the best for their personal future. At the same time, we are looking forward to working with Elaine Jones and the other The existing directors Ruedi Lanz, Germano Giuliani and Stella Xu.' comments Chairman Hans Peter Hasler.

Contact
For further information, please contact Dr Andreas Wicki on +41 41 710 75 77, or at andreas.wicki@hbmhealthcare.com.



End of ad hoc announcement
Language: English
Company: HBM Healthcare Investments AG
Bundesplatz 1
6300 Zug
Switzerland
Phone: +41438887171
Fax: +41438887172
E-mail: info@hbmhealthcare.com
Internet: https://www.hbmhealthcare.com
ISIN: CH0012627250
Valor: 1262725
Listed: SIX Swiss Exchange
EQS News ID: 1193722

 
End of Announcement EQS Group News Service

1193722  07-May-2021 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1193722&application_name=news&site_id=symex

HBM HEALTHCARE INVESTMENTS AG's latest news


16/04/2024 17:47
02/04/2024 17:48
02/04/2024 17:46
18/03/2024 17:47
01/03/2024 17:47
16/02/2024 17:47
01/02/2024 17:47
22/01/2024 06:45
16/01/2024 17:47
03/01/2024 18:15


Other stories

20/04/2024 08:51
20/04/2024 15:10
20/04/2024 08:26
20/04/2024 11:20
20/04/2024 14:31
20/04/2024 13:27
20/04/2024 13:34
20/04/2024 09:15
20/04/2024 10:59
20/04/2024 14:12
20/04/2024 11:25
20/04/2024 12:50
19/04/2024 06:52
20/04/2024 11:44
20/04/2024 14:01
20/04/2024 04:45
19/04/2024 01:56
19/04/2024 10:01
19/04/2024 11:39
20/04/2024 05:35
19/04/2024 12:17
19/04/2024 18:00
20/04/2024 10:45
20/04/2024 09:45
19/04/2024 15:48
20/04/2024 03:58
20/04/2024 15:13
20/04/2024 08:21
20/04/2024 06:00
20/04/2024 12:30
20/04/2024 10:29
20/04/2024 09:37
19/04/2024 21:18
20/04/2024 14:25
19/04/2024 23:53
20/04/2024 08:56
20/04/2024 10:53
20/04/2024 10:53